Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Dundee Corp DNDPF


Primary Symbol: T.DC.A Alternate Symbol(s):  T.DC.P.D | DNDEF | DDEJF | T.DC.P.B

Dundee Corporation is a Canada-based holding company. Through its operating segments, the Company is a mining- focused investor primarily engaged in acquiring mineral resource assets. Its segments include Corporate and Other Portfolio Holdings; Goodman & Company, Investment Counsel Inc.; Dundee Sustainable Technologies Inc.; United Hydrocarbon International Corp., and Dundee 360 Real Estate Corporation. Corporate and Other Portfolio Holdings segment invests in public and private equity and debt securities in diversified industry segments. Goodman & Company, Investment Counsel Inc. includes the activities of Dundee Global Investment Management Inc. Dundee Sustainable Technologies Inc., a 78%-owned subsidiary developing patented sustainable precious and base metals extraction processes. United Hydrocarbon International Corp., an 84%-owned private subsidiary engaged in oil and gas exploration through the holding of a royalty interest in the Republic of Chad.


TSX:DC.A - Post by User

Post by jrj90620on Apr 25, 2024 6:53pm
56 Views
Post# 36008294

Doctors sceptical on current Alzheimers drugs

Doctors sceptical on current Alzheimers drugsHopefully Tau is better.

https://www.reuters.com/business/healthcare-pharmaceuticals/alzheimers-drug-adoption-us-slowed-by-doctors-skepticism-2024-04-23/?utm_source=Sailthru&utm_medium=Newsletter&utm_campaign=Health-Rounds&utm_term=042524&user_email=97c0d074ece59d548bd3b6da257204b177f4478633fac52a50a24e09c01df7a0
<< Previous
Bullboard Posts
Next >>